· Published by Health Canada · Official notice
| Brand | Lot | Product Name | Market Authorization | Dosage Form | Strength |
|---|---|---|---|---|---|
| Lumi Lash | 20220331 | Lumi Lash | No market authorization | Liquid | N/A |
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.